Fagron NV
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
25 apr 2013 - 07:36
Statutaire naam
Fagron NV
Titel
Arseus: Acquisition of United States based Freedom Pharmaceuticals
Bericht
Fagron creates a strong and nation-wide U.S. coverage, immediately delivering extra value to customers
Waregem (Belgium) / Rotterdam (the Netherlands)[1], 25 April 2013 - Arseus announces today the acquisition of Freedom Pharmaceuticals, a leading supplier of pharmaceutical raw materials, excipients, bases and capsules to independent compounding pharmacies throughout the United States. In 2013, Freedom Pharmaceuticals expects to achieve turnover of approximately US$ 25 million with an EBITDA margin above the average for the Fagron Group. Fagron paid a multiple of 5.5 times EBITDA for this acquisition. Freedom Pharmaceuticals will be consolidated as of 1 April 2013.
Datum laatste update: 27 juli 2024